DK115842B - Fremgangsmåde til fremstilling af terapeutisk aktive substituerede 4-aminobutynylsuccinimider eller 4-aminobutynylglutarimider eller syreadditionssalte deraf. - Google Patents

Fremgangsmåde til fremstilling af terapeutisk aktive substituerede 4-aminobutynylsuccinimider eller 4-aminobutynylglutarimider eller syreadditionssalte deraf.

Info

Publication number
DK115842B
DK115842B DK315765AA DK315765A DK115842B DK 115842 B DK115842 B DK 115842B DK 315765A A DK315765A A DK 315765AA DK 315765 A DK315765 A DK 315765A DK 115842 B DK115842 B DK 115842B
Authority
DK
Denmark
Prior art keywords
aminobutynylsuccinimides
aminobutynylglutarimides
preparation
acid addition
addition salts
Prior art date
Application number
DK315765AA
Other languages
Danish (da)
English (en)
Inventor
J Dahlbom
B Karlen
Original Assignee
Astra Apotekarnes Kem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Apotekarnes Kem Fab filed Critical Astra Apotekarnes Kem Fab
Publication of DK115842B publication Critical patent/DK115842B/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36Oxygen or sulfur atoms
    • C07D207/402,5-Pyrrolidine-diones
    • C07D207/4042,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86Oxygen atoms
    • C07D211/88Oxygen atoms attached in positions 2 and 6, e.g. glutarimide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
DK315765AA 1964-07-03 1965-06-22 Fremgangsmåde til fremstilling af terapeutisk aktive substituerede 4-aminobutynylsuccinimider eller 4-aminobutynylglutarimider eller syreadditionssalte deraf. DK115842B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8163/64A SE300422B (de) 1964-07-03 1964-07-03

Publications (1)

Publication Number Publication Date
DK115842B true DK115842B (da) 1969-11-17

Family

ID=20273317

Family Applications (1)

Application Number Title Priority Date Filing Date
DK315765AA DK115842B (da) 1964-07-03 1965-06-22 Fremgangsmåde til fremstilling af terapeutisk aktive substituerede 4-aminobutynylsuccinimider eller 4-aminobutynylglutarimider eller syreadditionssalte deraf.

Country Status (5)

Country Link
US (1) US3444171A (de)
DK (1) DK115842B (de)
FI (1) FI45043C (de)
GB (1) GB1079467A (de)
SE (1) SE300422B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4065471A (en) * 1965-04-09 1977-12-27 Sterling Drug Inc. N-(4-Amino-2-butynyl)imides
US3862130A (en) * 1970-04-27 1975-01-21 Goodrich Co B F Alkylhydroxyp henylcarboalkoxy-substituted nitrogen heterocycles
DE2411019C2 (de) * 1973-03-16 1986-11-20 Nelson Research & Development Co., Irvine, Calif. Verwendung von 1-(4-(1-Pyrrolidinyl)-2-butynyl)-2-pyrrolidinon oder 1-(2-Oxo-1-pyrrolidin)-4-(1-pyrrolidin)-2-butyn zur Behandlung von Glaucoma
CH677924A5 (de) * 1987-02-25 1991-07-15 Egyt Gyogyszervegyeszeti Gyar

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL255251A (de) * 1959-08-28
US3317526A (en) * 1964-07-16 1967-05-02 Astra Ab Omega-tertiaryamino butynol-1-phenylcycloalkane carboxylates
US3354178A (en) * 1965-04-09 1967-11-21 Sterling Drug Inc Nu-(4-amino-2-butynyl)-nu-alkylcarboxamides

Also Published As

Publication number Publication date
FI45043C (fi) 1972-03-10
FI45043B (de) 1971-11-30
GB1079467A (en) 1967-08-16
US3444171A (en) 1969-05-13
SE300422B (de) 1968-04-29

Similar Documents

Publication Publication Date Title
DK115847B (da) Fremgangsmåde til fremstilling af terapeutisk aktive 2,4-diamino-5-benzyl-pyrimidinderivater eller syreadditionssalte deraf.
DK130586B (da) Analogifremgangsmåde til fremstilling af 5-alkyl- eller 5-alkoksybenzimidazol-2-karbamater eller syreadditionssalte deraf.
DK133372B (da) Analogifremgangsmåde til fremstilling af terapeutisk aktive hydroxy-cyclohexyl-aminer eller syreadditionssalte deraf.
DK108169C (da) Fremgangsmåde til fremstilling af 3-hydroxy-5-aminomethyl-isoxasol eller syreadditionssalte deraf.
DK134222B (da) Analogifremgangsmåde til fremstilling af terapeutisk virksomme aminer eller syreadditionssalte deraf.
DK114200B (da) Fremgangsmåde til fremstilling af terapeutisk virksomme, basisk substituerede cycloalkenderivater eller syreadditionssalte deraf.
DK107288C (da) Fremgangsmåde til fremstilling af arylalkylaminoguanidiner eller syreadditionssalte deraf.
DK114618B (da) Fremgangsmåde til fremstilling af α-dithiosemicarbazoner eller syreadditionssalte deraf.
DK127599B (da) Analogifremgangsmåde til fremstilling af terapeutisk virksomme 2,4-diaminosubstituerede quinazolin-forbindelser eller syreadditionssalte heraf.
DK126592B (da) Analogifremgangsmåde til fremstilling af substituerede 2-anilinopyridiner eller syreadditionssalte deraf.
DK117835B (da) Fremgangsmåde til fremstilling af terapeutisk virksomme N-4-pyrimidinyl-anthranilsyreforbindelser eller salte deraf.
DK109988C (da) Fremgangsmåde til fremstilling af basisk substituerede 2-oxo-benzimidazoliner eller syreadditionssalte deraf.
DK115110B (da) Fremgangsmåde til fremstilling af anticholeterolemeisk sktive 25-aza-19-nor-1,3,5(10)-cholestatriener eller syreadditionssalte deraf.
DK122327B (da) Analogifremgangsmåde til fremstilling af N-alkyllincomycin D-forbindelser eller syreadditionssalte deraf.
DK115842B (da) Fremgangsmåde til fremstilling af terapeutisk aktive substituerede 4-aminobutynylsuccinimider eller 4-aminobutynylglutarimider eller syreadditionssalte deraf.
DK115703B (da) Fremgangsmåde til fremstilling af N-alkylpolyhydrobenzazepinopyridoindoler eller syreadditionssalte deraf.
DK114059B (da) Fremgangsmåde til fremstilling af terapeutisk aktive benzamidoacetamidinderivater med antidepressiv virkning eller syreadditionssalte deraf.
DK111031B (da) Fremgangsmåde til fremstilling af N-aralkylpiperidin-derivater eller syreadditionssalte deraf.
DK124614B (da) Fremgangsmåde til fremstilling af 3-(3-piperidino- eller morpholinopropionyl)-5-phenylisoxazolderivater eller syreadditionssalte deraf.
DK108394C (da) Fremgangsmåde til fremstilling af substituerede imidazo- eller pyrimido-quinazoliner eller syreadditionssalte deraf.
DK128416B (da) Analogifremgangsmåde til fremstilling af adrenocorticotropt aktive nonadecapeptidamider eller syreadditionssalte eller kompleksforbindelser deraf.
DK116213B (da) Fremgangsmåde til fremstilling af dibenzocycloheptenylestre eller syreadditionssalte heraf.
DK121375B (da) Analogifremgangsmåde til fremstilling af N-aminoalkylbenzazacycloalkanderivater eller syreadditionssalte heraf.
DK114964B (da) Analogifremgangsmåde til fremstilling af terapeutisk virksomme α-substituerede 1-naftylacetamider eller syreadditionssalte deraf.
DK112658B (da) Fremgangsmåde til fremstilling af terapeutisk aktive 1-acyl-substituerede quinolizinforbindelser eller syreadditionssalte deraf.